Bank of Scotland Unveils LimitedEdition 20 Note Featuring Scott McTominays Iconic Goal Chinas Seven Titans Tech Stocks Face Pressure as Deflation Concerns Weigh on AI Enthusiasm Michael Saylor Tokenization Could Allow Investors to Shop for Yield Challenging Traditional Banking Traders Now Expect Next Fed Rate Move Could Be a Hike by December British Startup BioOrbit Sends DrugCrystallization Technology to ISS for Potential Cancer Treatment Breakthrough Chinese Drone Shipments Decline Amid Domestic Restrictions and US Ban MUSA Q1 2026 Earnings EPS Surges 415 Above Estimates Stock Slightly Declines Ready Capital Corporation RC Q1 2026 Earnings Massive EPS Miss Signals Severe Challenges RCUS Q1 2026 Earnings EPS Misses Estimates as Pipeline Development Remains Key Focus Ginkgo Bioworks DNA Q1 2026 Earnings EPS Misses Estimates Stock Gains Despite Headwinds BFRI Q1 2026 Earnings Significant EPS Miss Yet Stock Rises on Operating Discipline VenHub Global Inc VHUB Gains Nearly 5 as Price Approaches Resistance Travere Therapeutics TVTX Edges Lower 069 as Shares Consolidate Between Support and Resistance Entergy Louisiana Bond ELC Holds Steady Near 2032 as Yield Environment Shifts Huntington Bancshares Preferred Stock HBANM Holds Steady Amid Modest Decline XCHG Limited XCH Rebounds From Key Support Resistance Test Ahead UK Chancellor Reeves Announces VAT Cuts for Theme Park Tickets and Childrens Meals to Ease CostofLiving Pressures VRTS Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly Life Time Group Holdings LTH Gains 36 as Shares Test Key Resistance Zone American Drive Acquisition Corp ADACU Holds Steady Near Trust Value as SPAC Units Trade Flat Passage Bio PASG Holds Steady Near Support as Gene Therapy Sector Faces Crosscurrents Yorkville Acquisition Corp Warrant MCGAW Edges Higher Key Levels and Speculative Dynamics James River Group JRVR Holds Near Key Support After Marginal Uptick Liberty Broadband LBRDA Slips 267 as Selling Pressure Intensifies Near Key Support Netflix NFLX Edges Lower Testing Key Support Levels Amid Mixed Sentiment Agenus AGEN Rallies 22 Biotech Momentum Faces Key Resistance at 356